International Session 15  Cancer Chemotherapy

Genomic alterations converging in persistent activation of the PI3K/mTOR pathway represent one of the most frequently altered signaling circuitries in cancer.This abnormal activation is observed in about 80 of Head and neck squamous cell carcinoma(HNSCC)cases.This overreliance on PI3K/mTOR signaling for tumor growth may expose a cancer vulnerability that can be exploited therapeutically.However, the clinical efficacy of mTOR inhibitors(mTORi)for HNSCC treatment has been limited.Here, we took advantage of a whole-genome CRISPR screening approach to search for mechanisms making cells resistant to mTORi, and autophagy and ferrroptosis was identified.Ferroptosis is iron-dependent regulated cell death process caused by the peroxidation of polyunsaturated fatty acids.Indeed, mTORi was demonstrated to induce ferroptosis in HNSCC cells, and inhibition of ferroptosis reduced the effect of mTORi.This study provides direct and detailed mechanisms linking mTORi-triggered autophagy and ferroptosis.Our studies uncovered how mTORi act in HNSCC, thereby revealing new multimodal precision therapies for HNSCC and many human malignancies displaying overactive PI3K/mTOR signaling.

Authors

Institutions

Publication Details

Journal
Nippon Jibiinkoka Tokeibugeka Gakkai Kaiho(Tokyo)
Published
2025-04-20
DOI
https://doi.org/10.3950/jibiinkotokeibu.128.4_593
Primary Topic
Cancer Treatment and Pharmacology
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

International Session 15  Cancer Chemotherapy

Muneyuki Masuda, Chair Kazuaki Chikamatsu
Nippon Jibiinkoka Tokeibugeka Gakkai Kaiho(Tokyo)
Cancer Treatment and Pharmacology
article

International Session 15  Cancer Chemotherapy

Muneyuki Masuda, Chair Kazuaki Chikamatsu
article en

Abstract

Genomic alterations converging in persistent activation of the PI3K/mTOR pathway represent one of the most frequently altered signaling circuitries in cancer.This abnormal activation is observed in about 80 of Head and neck squamous cell carcinoma(HNSCC)cases.This overreliance on PI3K/mTOR signaling for tumor growth may expose a cancer vulnerability that can be exploited therapeutically.However, the clinical efficacy of mTOR inhibitors(mTORi)for HNSCC treatment has been limited.Here, we took advantage of a whole-genome CRISPR screening approach to search for mechanisms making cells resistant to mTORi, and autophagy and ferrroptosis was identified.Ferroptosis is iron-dependent regulated cell death process caused by the peroxidation of polyunsaturated fatty acids.Indeed, mTORi was demonstrated to induce ferroptosis in HNSCC cells, and inhibition of ferroptosis reduced the effect of mTORi.This study provides direct and detailed mechanisms linking mTORi-triggered autophagy and ferroptosis.Our studies uncovered how mTORi act in HNSCC, thereby revealing new multimodal precision therapies for HNSCC and many human malignancies displaying overactive PI3K/mTOR signaling.

Nippon Jibiinkoka Tokeibugeka Gakkai Kaiho(Tokyo)Vol. 128(4)
Gunma University (JP), National Hospital Organization Kyushu Cancer Center (JP)
Openalex Percentile: Top 60%
Cancer Treatment and Pharmacology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

International Session 15  Cancer Chemotherapy — Muneyuki Masuda, Chair Kazuaki Chikamatsu · Nippon Jibiinkoka Tokeibugeka Gakkai Kaiho(Tokyo) (2025) | TGRS Research Map | TGRS